CYP19A1 and breast carcinoma: In our study, we first determined that the expression of CYP19A1 in the plasma of drug-resistant breast cancer patients was significantly upregulated, indicated that the effect of CYP19A1 on drug sensitivity in breast cancer may be bidirectional.